How should organisations protect health data that sits outside HIPAA scope?

Why This Matters for Security Teams

Health data outside HIPAA often lives in systems that were never designed for regulated information: consumer wellness apps, customer support platforms, analytics pipelines, marketing tools, and AI-enabled services. That creates a false sense of safety because the data is not covered by one familiar rule set, even though it can still expose diagnosis patterns, medication use, pregnancy status, mental health details, or treatment history. Security teams should treat the issue as a data governance problem first and a compliance problem second.

The practical risk is not only disclosure. Health data can be copied into logs, shared with vendors, retained longer than intended, or used to train models without meaningful review. A control baseline aligned to the NIST Cybersecurity Framework 2.0 helps teams connect identification, protection, detection, response, and recovery around sensitive data rather than around a single law. That is especially important when health-related records are fragmented across business units and third parties.

In practice, many security teams encounter exposure only after a vendor integration, analytics export, or AI workflow has already propagated the data beyond its original purpose, rather than through intentional design.

How It Works in Practice

Protecting out-of-scope health data starts with discovery. Organisations need a complete inventory of where the data appears, how it is labelled, who can access it, and which systems create derived copies. That inventory should include structured records, free text, images, event logs, and embedded fields inside customer experience or product telemetry systems. Without that map, minimisation and retention controls are guesswork.

Once identified, the data should be classified by sensitivity and handled with layered controls. Current guidance suggests using the least amount of data required for the business purpose, then segmenting access so that support staff, analysts, developers, and vendors do not inherit broad visibility by default. The NIST SP 800-53 Rev 5 Security and Privacy Controls provides a useful control vocabulary for access restriction, audit logging, media protection, retention, and sanitisation. For teams using automation or non-human accounts, the OWASP Non-Human Identity Top 10 is directly relevant because service accounts, API keys, and tokens often become the easiest path to accidental overexposure.

• Classify health data wherever it appears, including in backups, tickets, exports, and model inputs.
• Apply purpose limitation so each dataset has a documented business use and retention period.
• Restrict access with role-based controls, segmented environments, and time-bound exceptions.
• Log access to sensitive fields and review vendor and machine access separately from human access.
• Prevent uncontrolled reuse in BI tools, AI prompts, and training datasets unless explicitly approved.

This is also where identity governance matters. If service accounts, integrations, and agentic workflows can retrieve health data, they need the same scrutiny as human users, including ownership, rotation, and revocation. These controls tend to break down when health data is embedded in SaaS workflows with weak field-level classification because downstream copies are hard to find and harder to remove.

Common Variations and Edge Cases

Tighter data controls often increase operational overhead, requiring organisations to balance usability, analytics value, and privacy risk against slower workflows and more restrictive access reviews.

One common edge case is de-identified or pseudonymised health data. Best practice is evolving here: the label alone does not make the data safe, because re-identification risk can persist when datasets are combined. Another complication is employee health information, which may fall under employment, benefits, or occupational safety rules even when HIPAA does not apply. Teams should not assume one policy covers all contexts.

AI creates a separate set of issues. Health-related prompts, chat transcripts, and retrieval-augmented generation content can leak sensitive attributes into model logs or downstream outputs. Where non-human identities or AI agents can call tools, governance should cover prompt routing, output validation, and token scoping, not just user permissions. That intersection is increasingly important for systems that ingest customer messages or support tickets containing health details.

There is also no universal standard for exactly when consumer wellness data becomes sensitive health data, so organisations should default to conservative classification where the content could reveal condition, treatment, or status. In practice, legal scope is often narrower than risk scope, and the safer operating model is to govern the data as sensitive until its lifecycle is fully understood.

Related resources from NHI Mgmt Group

• How can organisations tell whether an AI agent is acting outside its intended scope?
• Who is accountable when sensitive data is shared outside approved scope?
• How should organisations govern sensitive data moving outside Microsoft 365?
• How should regulated organisations protect data integrity when records move between paper and electronic systems?